Amedisys (AMED) Tops Q4 EPS by 1c, Revs Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Amedisys Reports Fourth Quarter and Year End 2019 Financial Results and Issues 2020 Guidance
February 18, 2020 4:15 PM ESTBATON ROUGE, La., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three month period and year ended December 31, 2019.
Three Month Periods Ended December 31, 2019 and 2018
Net service revenue increased $66.3Â million to $500.7Â million compared to $434.4Â million in 2018.Net income attributable to Amedisys, Inc. of $27.7Â million compared to $27.5Â million in 2018.Net income attributable to Amedisys, Inc. per diluted share of $0.83 compared to $0.84 in 2018.Adjusted Quarterly Results*
Adjusted EBITDA of $52.2Â million compared to $43.9Â million in 2018.Adjusted net service revenue of $500.7Â million compared to $434.4Â million in... More